METHOD OF TREATING METASTASES OF RENAL CELL CARCINOMA Russian patent published in 2010 - IPC A61K38/21 A61P35/00 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to oncology, and can be used in treatment of patients with generalised (disseminated) forms of renal cell carcinoma. Method is realised in the following way. Reaferon is introduced to patients intramuscularly, starting with 1 mln U, under control of body temperature dynamics and content of lymphocytes in leukocyte formula of blood. Reaferon dose is increased on 1 mln U with each next, in 1-2 days introduction, until body temperature rises to 37.5-38.0 degrees Celsius and will remain such during 2-3 hours after reaferon introduction, content of lymphocytes in leukocyte formula of blood a day after introduction being within 21-33%.

EFFECT: application of invention allows to reduce dimensions of metastases with monotherapy with reaferon due to adjustment of optimal reaferon dose depending on adaptive response of organism, reduce number of side effects and complications.

1 ex